Document is current
Any future updates will be listed below
-
Authors
McKinsey, Gabriel L. https://orcid.org/0000-0002-5503-2830
Santander, Nicolas https://orcid.org/0000-0001-8919-833X
Zhang, Xiaoming
Kleemann, Kilian L. https://orcid.org/0000-0002-2753-6804
Tran, Lauren
Katewa, Aditya
Conant, Kaylynn https://orcid.org/0000-0002-8114-4318
Barraza, Matthew
Waddell, Kian
Lizama, Carlos O. https://orcid.org/0000-0002-0471-8525
La Russa, Marie
Koo, Ji Hyun
Lee, Hyunji
Mukherjee, Dibyanti
Paidassi, Helena https://orcid.org/0000-0001-9915-4365
Anton, E. S.
Atabai, Kamran https://orcid.org/0000-0001-8170-7881
Sheppard, Dean https://orcid.org/0000-0002-6277-2036
Butovsky, Oleg https://orcid.org/0000-0003-0186-8867
Arnold, Thomas D. https://orcid.org/0000-0002-7310-5597
- License Information
-
More Information
Article History
Received: 31 January 2024
Accepted: 26 February 2025
First Online: 22 March 2025
Competing interests
: Drs Butovsky, Arnold and Sheppard have a financial interest in Glial Therapeutics, a company developing a new therapy to target ITGB8- TGFb signaling as a treatment for Alzheimer’s disease. Dr. Butovsky’s interests were reviewed and are managed by BWH and Mass General Brigham in accordance with their conflict of interest policies. The remaining authors declare no competing interests.
